Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Heart Failure × Valsartan × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Heart Failure 1

Interventions

sacubitril and valsartan sodium hydrate drug combination 2 Rituximab 2 pertuzumab 1 pegfilgrastim 1 obinutuzumab 1 nicotinamide-beta-riboside 1 dapagliflozin 1 acalabrutinib 1 Vincristine 1 Valsartan 1 Trastuzumab 1 Standard of Care 1 Specimen Handling 1 Pyruvic Acid 1 Prednisolone 1 Practice Guidelines as Topic 1 Ogivri 1 Mesenchymal Stem Cell Transplantation 1 Lenalidomide 1 Eplerenone 1 Electronic Health Records 1 Echocardiography 1 Doxorubicin 1 Dexrazoxane 1 Cyclophosphamide 1 Cardiac Resynchronization Therapy 1 Angiotensin-Converting Enzyme Inhibitors 1 Adrenergic beta-Antagonists 1 Ado-Trastuzumab Emtansine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05194111 2026-03-13

TREAT-HF

Virginia Commonwealth University

Phase 1/2 Recruiting

Heart Failure

Data powered by HemOnc (CC BY 4.0) Colophon ⚡